Literature DB >> 22713764

Anti-inflammatory and anti-atherogenic properties of adiponectin.

Koji Ohashi1, Noriyuki Ouchi, Yuji Matsuzawa.   

Abstract

Obesity-related disorders, such as insulin resistance, hypertension and atherosclerosis, are associated with chronic inflammation. Adiponectin is an adipocyte-derived secreted factor that is down-regulated in obese states. Adiponectin exerts the protective actions on obesity-linked diseases, such as insulin resistance and atherosclerosis by attenuating chronic inflammation in its target organs. Adiponectin also exerts the salutary effects on vascular disorders by directly acting on vascular component cells including endothelial cells, smooth muscle cells and macrophages. This review will focus on the role of adiponectin in control of inflammatory responses and atherogenic processes.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22713764     DOI： 10.1016/j.biochi.2012.06.008

Source DB:  PubMed          Journal:  Biochimie        ISSN： 0300-9084            Impact factor:   4.079


  80 in total

1.  Research advances in metabolism 2016.

Authors:  Nikolaos Perakakis; Olivia M Farr; Dario Tuccinardi; Jagriti Upadhyay; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-11-06       Impact factor: 8.694

2.  Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.

Authors:  Zhongjie Fu; Chatarina A Lofqvist; Zhuo Shao; Ye Sun; Jean-Sebastien Joyal; Christian G Hurst; Ricky Z Cui; Lucy P Evans; Katherine Tian; John Paul SanGiovanni; Jing Chen; David Ley; Ingrid Hansen Pupp; Ann Hellstrom; Lois E H Smith
Journal:  Am J Clin Nutr       Date:  2015-02-04       Impact factor: 7.045

3.  A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study.

Authors:  Xiaoling Song; Mark Kestin; Yvonne Schwarz; Pamela Yang; Xiaojun Hu; Johanna W Lampe; Mario Kratz
Journal:  Eur J Nutr       Date:  2015-02-04       Impact factor: 5.614

4.  Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.

Authors:  Sayaka Shibata; Yayoi Tada; Carren Sy Hau; Aya Mitsui; Masahiro Kamata; Yoshihide Asano; Makoto Sugaya; Takafumi Kadono; Yosuke Masamoto; Mineo Kurokawa; Toshimasa Yamauchi; Naoto Kubota; Takashi Kadowaki; Shinichi Sato
Journal:  Nat Commun       Date:  2015-07-15       Impact factor: 14.919

5.  Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia.

Authors:  J S R Machado; A C T Palei; L M Amaral; A C Bueno; S R Antonini; G Duarte; J E Tanus-Santos; V C Sandrim; R C Cavalli
Journal:  J Hum Hypertens       Date:  2013-06-27       Impact factor: 3.012

Review 6.  Proinflammatory phenotype of perivascular adipocytes.

Authors:  Abdullah Omar; Tapan K Chatterjee; Yaoliang Tang; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-12       Impact factor: 8.311

Review 7.  Murine models of sleep apnea: functional implications of altered macrophage polarity and epigenetic modifications in adipose and vascular tissues.

Authors:  Wojciech Trzepizur; Rene Cortese; David Gozal
Journal:  Metabolism       Date:  2017-11-16       Impact factor: 8.694

8.  Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

Authors:  William G Sanders; Huan Li; Ilya Zhuplatov; Yuxia He; Seong-Eun Kim; Alfred K Cheung; Jayant Agarwal; Christi M Terry
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

9.  Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses.

Authors:  Jinlong He; Yanhong Zhou; Junjie Xing; Qilong Wang; Huaiping Zhu; Yi Zhu; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-28       Impact factor: 8.311

10.  Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3.

Authors:  S Lallukka; K Sevastianova; J Perttilä; A Hakkarainen; M Orho-Melander; N Lundbom; V M Olkkonen; H Yki-Järvinen
Journal:  Diabetologia       Date:  2013-01-19       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.